Canaery-Led Research Team Funded by US National Science Foundation Convergence Accelerator

UF Innovate | Accelerate resident client Canaery, the neurotech company revolutionizing the detection of important scents in real-world settings, announced it has secured $650,000 in Phase 1 funding from the U.S. National Science Foundation (NSF) Convergence Accelerator leading an interdisciplinary team of scientists, engineers, and operators. Teams that complete Phase 1 may qualify for up to $5 million in Phase 2 funding.

The NSF Convergence Accelerator prioritizes projects with potential for positive societal and economic impact. The Canaery-led Phase 1 project, aligned under the program’s Track L: Real-World Chemical Sensing Applications, aims to create a safe fentanyl substitute for training scent detection animals, refine the Canaery nose-computer interface (NCI) system, and validate the system’s ability to detect fentanyl and smokeless gunpowder in real-world scenarios.

“For Phase 1 of the NSF Convergence Accelerator program we have assembled an expert team to demonstrate multiple simultaneous detections of critical odors in real-world environments,” said Peter Ledochowitsch, Ph.D., CTO and co-founder, Canaery. “The two most common uses of a detection canine today are for narcotics and explosives, new versions of which are constantly being developed. Fentanyl and smokeless powder will be two of the first entries into what will one day become the largest networked library of detectable odors in the world.”

Read more about Canaery-Led Research Team Funded by US National Science Foundation Convergence Accelerator.